{
    "clinical_study": {
        "@rank": "13323", 
        "arm_group": [
            {
                "arm_group_label": "Resistance training", 
                "arm_group_type": "Experimental", 
                "description": "Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR)."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The study aimed to evaluate the chronic effects of resistance training on blood pressure and\n      biochemical exams in hypertensive elderlies and the influence of the polymorphism of the\n      angiotensin converting enzyme in these response."
        }, 
        "brief_title": "Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "To investigate the chronic effects of resistance training on blood pressure and biochemical\n      exams in elderly, 135 hypertensive elderlies were divided into 2 groups: trained and\n      control. The trained group was submitted to a resistance training period. Before the 16\n      weeks ACE gene was genotyped (PCR). Before and after 16 weeks, blood pressure (ambulatory),\n      HDL-cholesterol, Total cholesterol, Glycemia, Triacylglycerol (colorimetric assay) and\n      plasminogen activator inhibition (PAI-1), intercellular adhesion molecule (ICAM-1), vascular\n      endothelial cell adhesion molecule (VCAM-1), Adiponectin, tumor necrosis factor alpha\n      (TNF-alpha), C Reactive Protein, Angiotensin II, Angiotensin Converting Enzyme, Angiotensin\n      1-7, (ELISA assay) were measured."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Hypertensives\n\n          -  Age 60 to 85 years\n\n          -  Nonactive\n\n        Exclusion Criteria:\n\n          -  Orthopedic problems or other problem that prevented the exercises\n\n          -  Change in drug treatment during protocol\n\n          -  Absence in more than 25% of the exercise sessions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "136", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963507", 
            "org_study_id": "ACE RT"
        }, 
        "intervention": {
            "arm_group_label": "Resistance training", 
            "description": "Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition  (MR).", 
            "intervention_name": "Resistance training", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Santos", 
                    "country": "Brazil", 
                    "state": "SP"
                }, 
                "name": "UNIMED"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Blood pressure was measured by Ambulatorial Monitoring Blood Pressure before and after 16 weeks of intervention.", 
            "measure": "Blood Pressure", 
            "safety_issue": "Yes", 
            "time_frame": "16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963507"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Alessandra Medeiros", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "HDL-cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.", 
                "measure": "HDL-cholesterol", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Total cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.", 
                "measure": "Total Cholesterol", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Glycemia was analyzed by colorimetric assay, before and after 16 weeks of intervention.", 
                "measure": "Glycemia", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Triacylglycerol was analyzed by colorimetric assay, before and after 16 weeks of intervention.", 
                "measure": "Triacylglycerol", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "PAI-1 was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "PAI-1", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "ICAM-1 was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "ICAM-1", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "VCAM-1 was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "VCAM-1", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Adiponectin was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "Adiponectin", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "TNF alpha was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "TNF alpha", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "C Reactive Protein was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "C Reactive Protein", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Angiotensin II was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "Angiotensin II", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Angiotensin Converting Enzyme was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "Angiotensin Converting Enzyme", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Angiotensin 1-7 was analyzed by ELISA assay,  before and after 16 weeks of intervention.", 
                "measure": "Angiotensin 1-7", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }
        ], 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "collaborator": {
                "agency": "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Federal University of S\u00e3o Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}